Benjamin F. Edwards & Company’s Verastem VSTM Stock Holding History

Benjamin F. Edwards & Company’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-112	Closed	-$1K	–	1848
2023 Q1	$1K	Hold	112	–	–	﹤0.01%	1756
2022 Q4	$1K	Hold	112	–	–	﹤0.01%	1817
2022 Q3	$1K	Hold	112	–	–	﹤0.01%	1792
2022 Q2	$2K	Hold	112	–	–	﹤0.01%	1721
2022 Q1	$2K	Hold	112	–	–	﹤0.01%	1681
2021 Q4	$3K	Hold	112	–	–	﹤0.01%	1613
2021 Q3	$4K	Hold	112	–	–	﹤0.01%	1576
2021 Q2	$5K	Hold	112	–	–	﹤0.01%	1529
2021 Q1	$3K	Hold	112	–	–	﹤0.01%	1593
2020 Q4	$3K	Hold	112	–	–	﹤0.01%	1506
2020 Q3	$2K	Hold	112	–	–	﹤0.01%	1601
2020 Q2	$2K	Hold	112	–	–	﹤0.01%	1599
2020 Q1	$4K	Hold	112	–	–	﹤0.01%	1512
2019 Q4	$2K	Hold	112	–	–	﹤0.01%	1794
2019 Q3	$2K	Hold	112	–	–	﹤0.01%	1768
2019 Q2	$2K	Hold	112	–	–	﹤0.01%	1813
2019 Q1	$4K	Hold	112	–	–	﹤0.01%	1544
2018 Q4	$5K	Buy	+112	New	+$6.84K	﹤0.01%	1479

Other funds holding VSTM

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Benjamin F. Edwards & Company's VSTM Position: Q2 2023 in Review

Benjamin F. Edwards & Company sold out of Verastem (VSTM) in Q2 2023, closing a stake of 112 shares — an estimated $1K sold.

Benjamin F. Edwards & Company first reported a position in VSTM in Q4 2018 and held it in 18 quarters. The position peaked at $5K in Q2 2021. 61 funds tracked by Wall St. Rank hold VSTM as of Q2 2023.

Benjamin F. Edwards & Company reported no remaining Verastem position as of Q2 2023 after selling out during the quarter.
Benjamin F. Edwards & Company sold 112 Verastem shares in Q2 2023, an estimated $1K.
Benjamin F. Edwards & Company first reported a position in Verastem in Q4 2018 and held it in 18 quarters.
Benjamin F. Edwards & Company's Verastem position peaked at $5K in Q2 2021.
61 funds tracked by Wall St. Rank held Verastem as of Q2 2023.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2023, filed 15 Aug 2023.